Sort
48,018 grants matching “immunotherapy”
Miami Pediatric AIDS Clinical Trials Unit
$1,133,574University Of Miami School Of Medicine · U01 · FY2002 · AI
A novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer
$1,133,263Jennifer June Sessions · Cynvec, Llc · R44 · FY2021 · CA
Immune function and the progression to type 1 diabetes
$1,133,123University Of Florida · P01 · FY2004 · AI
Myelodysplasia
$1,132,969Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Point-of-Care Microfluidics in Lung Cancer
$1,132,105Mehmet Toner · Massachusetts General Hospital · R01 · FY2007 · EB
Preclinical drug development in pancreatic cancer
$1,131,974Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Symptomatic Toxicities & Quality of Life among Diverse Individuals Receiving Immune Checkpoint Inhibitors for Metastatic Cancer.
$1,131,820Patricia Ingrid Moreno · University Of Miami School Of Medicine · R37 · FY2025 · CA
REGULATORY DENDRITIC CELL IMMUNOTHERAPY FOR TOLERANCE INDUCTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
$1,131,506University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2015 · Department of the Army
LF-TIMING: Large-scale label-free profiling of cell-cell interactions
$1,128,853Rebecca L Berdeaux · Cellchorus Inc. · R42 · FY2025 · TR
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$1,128,458Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,128,045Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2020 · CA
Functional Genomics of Sarcoma
$1,127,982Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$1,127,538Bryce Beverlin II · Quench Medical, Inc. · R44 · FY2023 · CA
Protein Expression Facility
$1,126,801Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2018 · ES
Core D: Antigen Receptor Identification and Tracking Core
$1,126,470Nir Hacohen · Massachusetts General Hospital · U19 · FY2020 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$1,126,470Raymond T Chung · Massachusetts General Hospital · U19 · FY2020 · AI
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$1,125,311Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2018 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$1,124,755Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,124,689Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,124,257Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
$1,124,111Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Neurosurgical Oncology Unit
$1,123,670Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
$1,123,263Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,122,409Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,122,303Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI